医学
冲程(发动机)
临床试验
随机对照试验
临床终点
栓塞
脑栓塞
缺血性中风
血管内治疗
半影
心脏病学
内科学
外科
缺血
动脉瘤
工程类
机械工程
作者
Huanwen Chen,Ji Man Hong,Patrik Michel,Bernard Yan,Seemant Chaturvedi
出处
期刊:JAMA Neurology
[American Medical Association]
日期:2024-08-12
被引量:1
标识
DOI:10.1001/jamaneurol.2024.2500
摘要
Recently, 6 randomized clinical trials-RESCUE-Japan-LIMIT (Recovery by Endovascular Salvage for Cerebral Ultra-Acute Embolism-Japan Large Ischemic Core Trial), ANGEL-ASPECT (Trial of Endovascular Therapy for Acute Ischemic Stroke With Large Infarct), SELECT2 (Trial of Endovascular Thrombectomy for Large Ischemic Strokes), TESLA (Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke), TENSION (Endovascular Thrombectomy for Acute Ischemic Stroke With Established Large Infarct), and LASTE (Large Stroke Therapy Evaluation)-have concluded their investigations on the efficacy and safety of endovascular thrombectomy (EVT) for the treatment of patients with ischemic stroke, anterior-circulation large vessel occlusions, and large areas of ischemic changes defined as an Alberta Stroke Program Early Computed Tomography Score (ASPECTS) of 5 or less. Overall, the results appeared to be positive, with 5 of the 6 trials meeting their primary efficacy end point, and 1 trial that was a near miss. However, questions remain regarding how these trial results should be interpreted and incorporated into routine clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI